BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2374578)

  • 1. Bad blood between Red Cross and FDA.
    Gershon D
    Nature; 1990 Jul; 346(6281):210. PubMed ID: 2374578
    [No Abstract]   [Full Text] [Related]  

  • 2. Review demanded on Canadian blood.
    Science; 1992 Dec; 258(5090):1878-9. PubMed ID: 1470910
    [No Abstract]   [Full Text] [Related]  

  • 3. A bloody mess. New safeguards will cut supplies of a lifesaving resource.
    Sobel RK
    US News World Rep; 2001 Sep; 131(8):36-9. PubMed ID: 11550392
    [No Abstract]   [Full Text] [Related]  

  • 4. Red Cross reorganizes to ensure blood safety.
    Wagner L
    Mod Healthc; 1991 Nov; 21(47):15. PubMed ID: 10114994
    [No Abstract]   [Full Text] [Related]  

  • 5. How FDA safeguards the blood supply.
    Stone BW
    FDA Consum; 1991 Jun; 25(5):12-5. PubMed ID: 10111728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pressure grows over US blood ban.
    Goodman S
    Nature; 2001 Aug; 412(6846):467. PubMed ID: 11484010
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA, Red Cross reach agreement to improve blood safety.
    Rados C
    FDA Consum; 2003; 37(4):34-5. PubMed ID: 12971347
    [No Abstract]   [Full Text] [Related]  

  • 8. Banishing white blood cells. Safety group urges FDA to adopt new rules for prefiltering blood.
    Becker C
    Mod Healthc; 2001 Feb; 31(8):60-1. PubMed ID: 11234177
    [No Abstract]   [Full Text] [Related]  

  • 9. Patient safety or profit: what incentives are blood shield laws and FDA regulations creating for the tissue banking industry?
    Williams JL
    Indiana Health Law Rev; 2005; 2(1):295-328. PubMed ID: 17111505
    [No Abstract]   [Full Text] [Related]  

  • 10. Gen-Probe, Chiron and US Red Cross to investigate new technology to provide an extra layer of safety to the blood supply.
    Front Med Biol Eng; 1999; 9(1):96-8. PubMed ID: 10354914
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA could OK costly blood standards. An expert says that like chicken soup, removal of white cells from blood supply can't hurt.
    Hensley S
    Mod Healthc; 1999 Nov; 29(48):8. PubMed ID: 10662211
    [No Abstract]   [Full Text] [Related]  

  • 12. FDA accuses Red Cross of unsafe practices. Inspections at embattled blood bank turn up 'serious' violations.
    Becker C
    Mod Healthc; 2001 Dec; 31(51):10. PubMed ID: 11820197
    [No Abstract]   [Full Text] [Related]  

  • 13. Bad blood.
    Newman RJ; Podolsky D; Loeb P
    US News World Rep; 1994 Jun; 116(25):68-70, 72-8. PubMed ID: 10134824
    [No Abstract]   [Full Text] [Related]  

  • 14. Blood investigation.
    AIDS Policy Law; 1996 May; 11(9):12. PubMed ID: 11363471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of bad blood. Transfusion risks are low, but here's how to make them even lower.
    Findlay S
    US News World Rep; 1991 Jun; 110(21):71-2. PubMed ID: 10111465
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA seeks tighter rules on blood donors.
    Kaye D
    Clin Infect Dis; 2001 Oct; 33(8):i. PubMed ID: 11669068
    [No Abstract]   [Full Text] [Related]  

  • 17. Guidelines for recall of blood from AIDS donors? FDA says no.
    Med World News; 1983 Aug; 24(16):24. PubMed ID: 10261844
    [No Abstract]   [Full Text] [Related]  

  • 18. New variant CJD fears threaten blood supplies.
    Senior K
    Lancet; 2001 Jul; 358(9278):304. PubMed ID: 11498226
    [No Abstract]   [Full Text] [Related]  

  • 19. Biologics products; establishment registration and product listing for manufacturers of human blood and blood products; amendment to exempt certain transfusion services from registration--FDA. Final rule.
    Fed Regist; 1984 Aug; 49(171):34448-51. PubMed ID: 10299643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDA advises blood centers on phase-in of AIDS test.
    MLO Med Lab Obs; 1985 Apr; 17(4):21-3. PubMed ID: 10270782
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.